Dr. Peng Cai is a patent attorney practicing in the fields of chemistry and pharmaceutical development. Peng focuses his practice on U.S. and international patent prosecution and patent portfolio management, including, preparing office action responses, performing freedom to operate (FTO) and patentability analyses, and conducting IP due diligence analyses for corporate transactions.
Prior to joining McCarter & English, Peng was a Big Pharma scientist and attorney with global pharmaceutical development experience from early phase to commercialization. In addition to his experience in intellectual property law, Peng has practical knowledge and experience in food and drug law, specifically in the area of Chemistry Manufacture Control (CMC) regulatory requirements for marketing authorization, and cGMP regulatory compliance.
Peng has several publications in peer-reviewed scientific journals, including a first-author publication in Biochemistry, and has presented in global pharmaceutical conference abroad.